Decision letter for "HDAC Inhibitors as Anticancer Drugs: Chemical Diversity, Clinical Trials, Challenges and Perspectives"

2026

View at publisher
DOI: 10.1039/d5ra09034b/v2/decision1
Cited by: 0

Fields of Study & Subjects

Histone Deacetylase Inhibitors Research Epigenetics and DNA Methylation Synthesis and biological activity

Publication details

Publication date
6 January 2026